Revascularization for cardiogenic shock

摘要

Mortality from cardiogenic shock remains frustrat- ingly high, while attempts to demonstrate benefit from revascularization have been fraught with difficulty. We have arrived at a point where we should accept that in shocked patients, inotropes are essentially palliative, that thrombolysis is of no value and that on balance, the evidence favours a policy of revascularization in selected patients. We still lack a sound basis on which to perform this Selection.